Join Growin Stock Community!

水星生醫*6932.TW Overview

TW StockBiotech. & Medical
(No presentation for 6932)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

水星生醫*（6932）Overall Performance

水星生醫*（6932）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

水星生醫*（6932） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

水星生醫*（6932）Key Information

水星生醫*（6932）Profile

Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.

水星生醫*（6932）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

6932

水星生醫*

8.50D

-2.82%

(-0.03)

  • When is 6932's latest earnings report released?

    The most recent financial report for 水星生醫* (6932) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6932's short-term business performance and financial health. For the latest updates on 6932's earnings releases, visit this page regularly.

  • How much cash does 6932 have?

    At the end of the period, 水星生醫* (6932) held Total Cash and Cash Equivalents of 67.32M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.